MetaCap

Who Owns Iovance Biotherapeutics Stock?

NASDAQ: IOVAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

6.90-0.41 (-5.61%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
69.15%
Institutional holders
428
  • Institutions 69.2%
  • Insiders 0.8%
  • Public and other 30.0%

Who owns Iovance Biotherapeutics stock?

Institutional investors own about 69.2% of Iovance Biotherapeutics's shares, spread across 428 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 0.82% of IOVA.

The largest institutional holders are Blackrock Inc. (8.19%), MHR Fund Management, LLC (6.26%) and State Street Corporation (4.69%). Together, the top 10 institutions control 36.5% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their IOVA positions and 5 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of IOVA

Iovance Biotherapeutics top institutional holders
InstitutionShares% HeldChange
Blackrock Inc.37.90M8.19%+2.6%
MHR Fund Management, LLC28.97M6.26%0.0%
State Street Corporation21.70M4.69%-11.4%
Two Sigma Investments, LP19.01M4.11%+38.9%
Vanguard Capital Management LLC18.40M3.98%+1.1%
Vanguard Portfolio Management LLC12.28M2.65%-14.7%
Geode Capital Management, LLC10.45M2.26%+1.2%
Millennium Management Llc8.53M1.84%-9.4%
Dimensional Fund Advisors LP6.24M1.35%-3.4%
Palo Alto Investors Lp5.30M1.14%-16.6%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of IOVA

Iovance Biotherapeutics top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund13.49M2.91%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF11.25M2.43%
iShares Trust-iShares Russell 2000 ETF10.29M2.22%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund4.86M1.05%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund4.36M0.94%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund4.31M0.93%
iShares Trust-iShares Russell 2000 Value ETF3.73M0.81%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund3.08M0.67%
iShares Trust-iShares Biotechnology ETF3.07M0.66%
TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fund2.71M0.59%

Frequently asked questions

Who is the largest shareholder of Iovance Biotherapeutics?

Blackrock Inc. is the largest institutional shareholder of IOVA, owning 8.19% of shares outstanding (37.90M shares) as of its latest 13F filing.

What percentage of Iovance Biotherapeutics is owned by institutions?

Institutions own about 69.2% of IOVA shares and 69.7% of the public float.

How much of Iovance Biotherapeutics do insiders own?

Insiders, such as officers and directors, own about 0.82% of IOVA shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related